Merus (MRUS)
(Real Time Quote from BATS)
$64.45 USD
-3.00 (-4.45%)
Updated Aug 6, 2025 12:54 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Merus N.V. has a market cap of $4.67B, which represents its share price of $67.45 multiplied by its outstanding shares number of 69.21M. As a mid-cap company, MRUS's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MRUS 64.45 -3.00(-4.45%)
Will MRUS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MRUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MRUS
Merus N.V. (MRUS) Reports Q2 Loss, Misses Revenue Estimates
BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
MRUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
Other News for MRUS
MRUS: Needham Maintains Buy Rating, Lowers Price Target | MRUS Stock News
Merus to Present at the Canaccord Genuity 45th Annual Growth Conference | MRUS Stock News
Merus (MRUS) Financial Position Strong with Funding Secured Until 2028
Merus (MRUS) Q2 Revenue Falls Short of Expectations, Exciting Clinical Developments Ahead
Merus GAAP EPS of -$2.23 misses by $1.05, revenue of $8.83M misses by $0.94M